It started to be interesting for the scientific community in 1997, when it was disclosed as major constituent of histopathological lesions in Parkinson’s disease (PD) [2], and a point mutation in the SNCA gene was discovered in families with the hereditary form of this disease [3]. This evidence concerns the gene SNCA and Parkinson disease.